VHL and renal carcinoma: By query from multiple clinical data sets [54–58], we observed that the expression levels of this VHL-S65P genetic signature were significantly higher in human renal carcinoma specimens than adjacent normal tissues (Fig. 6D, E and Additional File 3: Fig. S3).